Khartis Therapeutics Raises $50 Million in Series B Financing for Immunology Pipeline Expansion

Leila Ahmed North America Legal Chronicle
Tagged:

Wilson Sonsini Goodrich & Rosati has advised Khartis Therapeutics. Khartis Therapeutics, a biotechnology company specializing in oral small molecule medicines for immunological and chronic diseases, has…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here